Lyell (LYEL) Insider Report: RSU Vesting and Tax Withholding Sale
Rhea-AI Filing Summary
Stephen J. Hill, Chief Operating Officer and director of Lyell Immunopharma (LYEL), reported two equity transactions: 8,000 shares of common stock were issued on 08/20/2025 upon vesting of performance-based restricted stock units (4,000 shares vested immediately; 4,000 remain subject to service-through vesting on 08/20/2026). The reporting person then sold 1,004 shares on 08/21/2025 to cover tax withholding at a weighted-average price of $10.544 (sale prices ranged $10.49–$10.64). Share counts reported: 16,849 shares beneficially owned after issuance and 15,845 shares after the tax-withholding sale.
Positive
- Performance criteria achieved for the awarded RSUs, resulting in issuance of 8,000 common shares (4,000 vested immediately).
- Compensation committee certification of performance-based vesting indicates formal governance oversight of equity awards.
- Alignment of incentives preserved by leaving 4,000 performance shares subject to continued service through 08/20/2026.
Negative
- Automatic sale of 1,004 shares to cover tax withholding reduced the reporting person’s beneficial holdings from 16,849 to 15,845 shares.
- No information provided on the number of shares sold at each price within the reported $10.49–$10.64 range without SEC request.
Insights
TL;DR: Routine insider vesting and tax-withholding sale; modest share increase then partial divestiture, no material dilution or unusual trading behavior.
The filing documents the vesting of performance-based RSUs and a subsequent automatic sale to satisfy tax obligations. The net change in beneficial ownership is modest (16,849 to 15,845 shares) and the sale price range ($10.49–$10.64) is narrow, indicating routine settlement activity rather than discretionary market timing. No options, derivatives, or large dispositions were reported that would materially affect outstanding share count or signal major insider repositioning.
TL;DR: Governance procedures appear standard: performance-based equity vesting certified by compensation committee and automatic tax sale executed.
The disclosure notes the compensation committee certified achievement of performance criteria for the RSUs before issuance, reflecting governance oversight of award payouts. The remaining 4,000 performance shares remain subject to continued service through 08/20/2026, aligning management incentives with future performance. The automatic sale to cover tax withholding is a common administrative step and does not suggest governance or compliance concerns based on the information provided.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,004 | $10.544 | $11K |
| Grant/Award | Common Stock | 8,000 | $0.00 | -- |
Footnotes (1)
- Pursuant to performance-based restricted stock units granted to the reporting person on February 9, 2024, 4,000 shares were issued on the Transaction Date upon the achievement of certain performance criteria certified by the compensation committee of the Issuer's board of directors on the Transaction Date and 4,000 shares will be issued on August 20, 2026, subject to the reporting person providing service through such date. Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.49 to $10.64 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
